Cost-effectiveness of primary versus secondary prophylaxis with pegfilgrastim in women with early-stage breast cancer receiving chemotherapy.
about
Prophylaxis of chemotherapy-induced febrile neutropenia with granulocyte colony-stimulating factors: where are we now?Advances in the treatment of neutropenia.A way forward on the medically appropriate use of white cell growth factorsCost-utility analyses of drug therapies in breast cancer: a systematic review.Use and delivery of granulocyte colony-stimulating factor in breast cancer patients receiving neoadjuvant or adjuvant chemotherapy-single-centre experienceThe value of comparative effectiveness research: projected return on investment of the RxPONDER trial (SWOG S1007)How much is the life of a cancer patient worth? A pharmaco-economic perspective.Pharmacoeconomics of the myeloid growth factors: a critical and systematic review.Pegfilgrastim: a review of the pharmacoeconomics for chemotherapy-induced neutropenia.New G-CSF agonists for neutropenia therapy.Pharmacoeconomics of granulocyte colony-stimulating factor: a critical review.Cost-effectiveness of febrile neutropenia prevention with primary versus secondary G-CSF prophylaxis for adjuvant chemotherapy in breast cancer: a systematic review.Granulocyte colony-stimulating factors in the prevention of febrile neutropenia: review of cost-effectiveness models.Cost-effectiveness of filgrastim and pegfilgrastim as primary prophylaxis against febrile neutropenia in lymphoma patients.Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings.Cost-Utility Analysis of Lipegfilgrastim Compared to Pegfilgrastim for the Prophylaxis of Chemotherapy-Induced Neutropenia in Patients with Stage II-IV Breast CancerPersonalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy.Risk and healthcare costs of chemotherapy-induced neutropenic complications in women with metastatic breast cancer.Is febrile neutropenia prophylaxis with granulocyte-colony stimulating factors economically justified for adjuvant TC chemotherapy in breast cancer?Economic evaluation of using a genetic test to direct breast cancer chemoprevention in white women with a previous breast biopsy.Granulocyte colony-stimulating factor in secondary prophylaxis for advanced-stage Hodgkin lymphoma treated with ABVD chemotherapy: a cost-effectiveness analysis.
P2860
Q33756369-CAEB8660-E595-48FA-A66B-594B4238F629Q34609244-AECD353D-B889-4F22-BBEC-D2E9B3978F91Q36058245-10F45677-4E8E-4B06-8EE9-FB57D96A8DA0Q36116276-9B4AE22B-03DC-4D16-80A1-70F0F9974B6DQ36136876-AB9BF22A-721E-492C-989C-4DB5A031AE2DQ36364504-E30EC5C4-9981-430D-902F-4BD50D69A7D0Q37872357-BC535074-8266-4BCE-AC7E-8D4C06F1018DQ38006021-1D139D41-3B55-48AA-A223-2CCE2B92FC1BQ38068457-122E443B-F394-4952-BA0E-3817455FF690Q38145338-D27A293D-31E9-4969-BE52-70307BE1A522Q38225700-21281A78-AB66-44D5-9D24-9319D0EDDBF9Q38940016-F30A2609-0C9C-48A2-9B5F-A569704258B1Q39074316-84450C41-11CB-44E0-B95D-9B40CF0104ACQ40240657-70B11D99-AD08-46FA-92F7-A3C2C747261DQ40242261-FB8E25C5-0EA2-45B0-9253-0A4F5113A850Q41684418-156848B5-8526-4B05-9061-5569F8ED73CFQ42766829-BEF589DF-CCEB-4C31-8F65-3EB8C74AAE8FQ43421701-C0F5BB4F-910F-4ACF-89A7-CF6611451BB8Q48171553-6D6D95E9-555A-48A4-874C-58C1BD60F11EQ50460101-71E2F5C8-90BC-4C1B-A67F-4B17FC0ACA8DQ50892830-D0F89E34-A8D6-48D0-981A-090A1AAA2AB7
P2860
Cost-effectiveness of primary versus secondary prophylaxis with pegfilgrastim in women with early-stage breast cancer receiving chemotherapy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Cost-effectiveness of primary ...... cancer receiving chemotherapy.
@en
type
label
Cost-effectiveness of primary ...... cancer receiving chemotherapy.
@en
prefLabel
Cost-effectiveness of primary ...... cancer receiving chemotherapy.
@en
P2093
P1433
P1476
Cost-effectiveness of primary ...... cancer receiving chemotherapy.
@en
P2093
Gary H Lyman
Jennifer Malin
Quan V Doan
Robert W Dubois
Scott D Ramsey
Sean D Sullivan
Zhimei Liu
P304
P356
10.1111/J.1524-4733.2008.00434.X
P577
2008-07-31T00:00:00Z